| Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 … M Ilie, E Long-Mira, C Bence, C Butori, S Lassalle, L Bouhlel, L Fazzalari, ... Annals of Oncology 27 (1), 147-153, 2016 | 560 | 2016 |
| “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease M Ilie, V Hofman, E Long-Mira, E Selva, JM Vignaud, B Padovani, ... PloS one 9 (10), e111597, 2014 | 434 | 2014 |
| Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the … V Hofman, MI Ilie, E Long, E Selva, C Bonnetaud, T Molina, N Vénissac, ... International journal of cancer 129 (7), 1651-1660, 2011 | 377 | 2011 |
| Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker V Hofman, C Bonnetaud, MI Ilie, P Vielh, JM Vignaud, JF Fléjou, ... Clinical cancer research 17 (4), 827-835, 2011 | 373 | 2011 |
| Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients M Ilie, V Hofman, M Dietel, JC Soria, P Hofman Virchows Archiv 468, 511-525, 2016 | 255 | 2016 |
| Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What … M Ilie, V Hofman, E Long, O Bordone, E Selva, K Washetine, ... Annals of translational medicine 2 (11), 2014 | 232 | 2014 |
| Pros: Can tissue biopsy be replaced by liquid biopsy? M Ilié, P Hofman Translational lung cancer research 5 (4), 420, 2016 | 220 | 2016 |
| Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes H Cui, B Seubert, E Stahl, H Dietz, U Reuning, L Moreno-Leon, M Ilie, ... Oncogene 34 (28), 3640-3650, 2015 | 206 | 2015 |
| High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer M Ilie, NM Mazure, V Hofman, RE Ammadi, C Ortholan, C Bonnetaud, ... British journal of cancer 102 (11), 1627-1635, 2010 | 200 | 2010 |
| Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC C Sanfiorenzo, MI Ilie, A Belaid, F Barlesi, J Mouroux, CH Marquette, ... PloS one 8 (1), e54596, 2013 | 198 | 2013 |
| Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer M Ilié, E Szafer-Glusman, V Hofman, E Chamorey, S Lalvée, E Selva, ... Annals of Oncology 29 (1), 193-199, 2018 | 194 | 2018 |
| ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma M Ilie, E Long, C Butori, V Hofman, C Coelle, V Mauro, K Zahaf, ... Annals of oncology 23 (11), 2907-2913, 2012 | 183 | 2012 |
| Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer M Ilie, V Hofman, C Ortholan, C Bonnetaud, C Coëlle, J Mouroux, ... Cancer 118 (6), 1726-1737, 2012 | 183 | 2012 |
| Fibronectin-guided migration of carcinoma collectives S Gopal, L Veracini, D Grall, C Butori, S Schaub, S Audebert, L Camoin, ... Nature communications 8 (1), 14105, 2017 | 182 | 2017 |
| Cadmium-induced autophagy in rat kidney: an early biomarker of subtoxic exposure A Chargui, S Zekri, G Jacquillet, I Rubera, M Ilie, A Belaid, C Duranton, ... Toxicological Sciences 121 (1), 31-42, 2011 | 173 | 2011 |
| Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls VJ Hofman, MI Ilie, C Bonnetaud, E Selva, E Long, T Molina, JM Vignaud, ... American journal of clinical pathology 135 (1), 146-156, 2011 | 172 | 2011 |
| Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site J Selves, E Long-Mira, MC Mathieu, P Rochaix, M Ilié Cancers 10 (4), 108, 2018 | 165 | 2018 |
| “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy E Torlakovic, HJ Lim, J Adam, P Barnes, G Bigras, AWH Chan, ... Modern Pathology 33 (1), 4-17, 2020 | 164 | 2020 |
| Morphological analysis of circulating tumour cells in patients undergoing surgery for non‐small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET … V Hofman, E Long, M Ilie, C Bonnetaud, JM Vignaud, JF Fléjou, ... Cytopathology 23 (1), 30-38, 2012 | 154 | 2012 |
| Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy JD Fumet, C Richard, F Ledys, Q Klopfenstein, P Joubert, B Routy, ... British journal of cancer 119 (8), 950-960, 2018 | 149 | 2018 |
